Immunization in Canada: a 6-year update.

Abstract

In the six years since the publication in this journal of “Immunization in Canada: a success to build on,” immunization programs in Canada have changed substantially. In this commentary, we will review the current status of immunization programs in Canada, highlighting vaccines newly introduced into Canada’s publicly funded programs. We will also describe immunization committees recently established in Canada and the role they play in Canada’s vaccine program decision-making process. Finally, we will briefly review new vaccines that may soon be available in Canada. In 2003, there was universal, publicly funded immunization against nine diseases in Canada (diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, hepatitis B, measles, mumps, and rubella).1 Despite the National Advisory Committee on Immunization’s (NACI) recommendations for immunization of infants against varicella, Neisseria meningitidis type C (meningococcal C conjugate vaccine), Streptococcus pneumoniae (pneumococcal conjugate vaccine), and against pertussis in adolescents, there were no publicly funded programs set-up at the time. Since 2003, new vaccines have been added to Canada’s list of universal, publicly funded programs. As well, NACI has released updates and statements on the recommended immunization schedules for certain diseases that were previously publicly funded in 2003. In 2003, NACI was the committee that provided recommendations on the use of vaccines in Canada.2 Although NACI’s role is to make national recommendations on vaccine use, the decision to implement a new vaccine into publicly funded immunization programs as well as the purchasing of the vaccine is the responsibility of the provinces and territories. Decision-making structures for each province/territory varied greatly and in part led to lack of standardization and inconsistencies in the immunization programs and schedules across Canada.3